307280 — Wonbiogen Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual income statement for Wonbiogen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	17,721	26,748	29,615	30,440
Cost of Revenue
Gross Profit	—	7,595	12,465	14,195	14,280
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	178	15,681	21,797	22,492	24,230
Operating Profit	-178	2,040	4,950	7,123	6,210
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-134	-796	3,667	7,157	6,422
Provision for Income Taxes
Net Income After Taxes	-104	-660	3,272	5,961	5,339
Minority Interest
Net Income Before Extraordinary Items
Net Income	-104	-716	3,206	5,497	5,690
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-104	-716	3,206	5,497	5,690
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-140	-104	474	724	825
Dividends per Share